Publications by authors named "Isabelle Ollivier-Hourmand"

Claim this Profile
E
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial.
Thierry Thévenot, Laure Elkrief, Christophe Bureau, Edouard Bardou-Jacquet, Isabelle Rosa, Isabelle Ollivier-Hourmand

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Methodological Considerations on Early Hemostatic Treatment for Spontaneous Rupture of HCC".
Apolline Commin, Chloé Metivier, Rémy Morello, Isabelle Ollivier-Hourmand

Liver Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in patients with refractory variceal bleeding treated with esophageal stents: A multicenter cohort study.
Delphine Weil, Morgane Clément, Charlotte Bouzbib, Jean-Paul Cervoni, Andrimalala Raoto, Isabelle Ollivier-Hourmand

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The socioeconomic environment and access to care affect the survival of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Thomas Chaigneau, Olivier Dejardin, Thi Thu Nga Nguyen, Anne-Marie Bouvier, Josephine Gardy, Isabelle Ollivier-Hourmand

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study.
François Villeret, Mohamed Bouattour, Jean-Frédéric Blanc, Jean-Marie Péron, Marilyne Debette-Gratien, Isabelle Ollivier-Hourmand

Liver Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.
Manon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, Mohamed Bouattour, Julien Edeline, Isabelle Ollivier-Hourmand

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Hemostatic Treatment Could Improve 30-Day Survival After Spontaneous Rupture of Hepatocellular Carcinoma.
Apolline Commin, Chloé Metivier, Manon Allaire, Jean Lubrano, Amandine Claudinot, Isabelle Ollivier-Hourmand

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy.
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, Amaddeo Giuliana, Thomas Decaens, Isabelle Ollivier-Hourmand

Eur J Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients.
Florian Veyre, Eleonora De Martin, Domitille Erard, Claire Francoz, Laure Elkrief, Isabelle Ollivier-Hourmand

Am J Gastroenterol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: A multicenter retrospective study.
Laure Elkrief, Corentin Denecheau-Girard, Marta Magaz, Michael Praktiknjo, Nicola Colucci, Isabelle Ollivier-Hourmand

Hepatology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular Liver Disease Group (VALDIG) initiative.
Raoel Maan, Mandy N Lauw, Loise China, David Patch, Anna Baiges, Isabelle Ollivier-Hourmand

Hepatology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors.
Isabelle Ollivier-Hourmand, Louise Lebedel, Berta Bartroli Alabau, Odile Goria, Christophe Bureau

J Hepatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
Sabrina Sidali, Raphaël Borie, Flore Sicre de Fontbrune, Kinan El Husseini, Pierre-Emmanuel Rautou, Isabelle Ollivier-Hourmand

Hepatology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience.
Paul Leideck, Gisèle Nkontchou, Laure Elkrief, Domitille Erard, Louis d'Alteroche, Isabelle Ollivier-Hourmand

Clin Res Hepatol Gastroenterol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016.
Bertille Comoz, Isabelle Ollivier-Hourmand, Anne-Marie Bouvier, Jean-Baptiste Nousbaum, Thi Thu Nga Nguyen

Liver Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
Jean-François David Cadranel, Isabelle Ollivier-Hourmand, Jacques Cadranel, Thierry Thevenot, Honoré Zougmore

BMC Gastroenterol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma.
Isabelle Ollivier-Hourmand, Manon Allaire, Jean Paul Cervoni,

J Hepatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Isabelle Ollivier-Hourmand, Yohann Repesse, Pierre Nahon, Cendrine Chaffaut, Thông Dao

Liver Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.
Aurélie Plessier, Marina Esposito-Farèse, Anna Baiges, Akash Shukla, Juan Carlos Garcia Pagan, Isabelle Ollivier-Hourmand

Am J Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive diagnosis and follow-up of vascular liver diseases.
Pierre-Emmanuel Rautou, Laure Elkrief, Marie Decraecker, Isabelle Ollivier-Hourmand, Aurélie Plessier

Clin Res Hepatol Gastroenterol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.
Chloé De Broucker, Aurélie Plessier, Isabelle Ollivier-Hourmand, Sébastien Dharancy, Christophe Bureau

J Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
Aurélie Walter, Marika Rudler, Pol Olivas, Lucile Moga, Eric Trépo, Isabelle Ollivier-Hourmand

Hepatology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malnutrition in patients with cirrhosis: Screen or treat?
Marie-Astrid Piquet, Florence Vasseur, Isabelle Ollivier-Hourmand, Benoît Dupont

Nutr Clin Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.
Eleonora De Martin, Audrey Coilly, Olivier Chazouillères, Olivier Roux, Jean-Marie Peron, Isabelle Ollivier-Hourmand

J Hepatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study.
Anthony Turpin, Thierry de Baere, Alexandra Heurgué, Karine Le Malicot, Isabelle Ollivier-Hourmand

Clin Res Hepatol Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis